Association of sodium-glucose cotransporter 2 inhibitors with the risk of incident anxiety and insomnia: a retrospective cohort study using the TriNetX database
{{output}}
Aim: Patients with type 2 diabetes have a higher prevalence of anxiety and insomnia. Comparative evidence on mental health outcomes of antihyperglycemic agents remains limited. ... ...
